Replies to post #36407 on EVIO Inc (EVIO)

[tarballmonger]

Using this model of $50K revenue/ year, and lets say: a 15X multiple and O/S of ~20 million shares, that would translate into about $.04/share added value.

Even double that is not a game changer. Now, having said that, 50 licensed labs would be interesting on top of some growing number of owned labs.

BTW/ I 'm not forgetting about any up front one time fees ($150,000, maybe but lets see it in writing), but those are cash flow helpful and limited in valuations. IMHO.

Of course this is all predicated on the A/S being shrunk and limited.

GLTA.